Subacute cutaneous lupus as a result of combined mitogen-activated protein kinase kinase and BRAF inhibitor therapy for melanoma

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume177
Publication statusPublished - 1 Jul 2017

Cite this